NeoGenomics, Inc. Sales Revenue, Services, Net (Deprecated 2018-01-31)
NeoGenomics, Inc. (NEO) reported Sales Revenue, Services, Net (Deprecated 2018-01-31) of $67.75 million for the 3-month period ending 2018-06-30, per its 10-Q filed 2018-08-06.
Discontinued › Expense Statement › Operating Expenses
us-gaap:SalesRevenueServicesNet · last filed 2018-08-06
- NeoGenomics, Inc. sales revenue, services, net (deprecated 2018-01-31) for the quarter ending 2018-06-30 was $67.75M, a 8.80% increase year-over-year.
- NeoGenomics, Inc. sales revenue, services, net (deprecated 2018-01-31) for the quarter ending 2018-03-31 was $63.42M, a 10.44% increase year-over-year.
- NeoGenomics, Inc. sales revenue, services, net (deprecated 2018-01-31) for the quarter ending 2017-12-31 was $67.79M, a 12.07% increase year-over-year.
- NeoGenomics, Inc. sales revenue, services, net (deprecated 2018-01-31) for the quarter ending 2017-09-30 was $63.05M, a 3.77% increase year-over-year.
- NeoGenomics, Inc. sales revenue, services, net (deprecated 2018-01-31) for fiscal 2017 was $258.61M, a 5.95% increase from fiscal 2016.
- NeoGenomics, Inc. sales revenue, services, net (deprecated 2018-01-31) for fiscal 2016 was $244.08M, a 144.57% increase from fiscal 2015.
- NeoGenomics, Inc. sales revenue, services, net (deprecated 2018-01-31) for fiscal 2015 was $99.80M, a 14.62% increase from fiscal 2014.
- NeoGenomics, Inc. sales revenue, services, net (deprecated 2018-01-31) for fiscal 2014 was $87.07M, a 31.00% increase from fiscal 2013.
| Period end | Sales Revenue, Services, Net (Deprecated 2018-01-31) 3 month | Sales Revenue, Services, Net (Deprecated 2018-01-31) 3 month as first filed | Sales Revenue, Services, Net (Deprecated 2018-01-31) 6 month | Sales Revenue, Services, Net (Deprecated 2018-01-31) 6 month as first filed | Sales Revenue, Services, Net (Deprecated 2018-01-31) 9 month | Sales Revenue, Services, Net (Deprecated 2018-01-31) 12 month |
|---|---|---|---|---|---|---|
| 2018-06-30 | $67.75M 10-Q · filed 2018-08-06 | $131.17M 10-Q · filed 2018-08-06 | $198.96M derived: sum of 3 quarters · filed 2018-08-06 | $262.01M derived: sum of 4 quarters · filed 2018-08-06 | ||
| 2018-03-31 | $63.42M 10-Q · filed 2018-05-08 | $131.22M derived: sum of 2 quarters · filed 2018-05-08 | $194.27M derived: sum of 3 quarters · filed 2018-05-08 | $256.53M derived: sum of 4 quarters · filed 2018-08-06 | ||
| 2017-12-31 | $67.79M 10-K · filed 2018-03-13 | $130.84M derived: sum of 2 quarters · filed 2018-03-13 | $193.11M derived: sum of 3 quarters · filed 2018-08-06 | $258.61M 10-K · filed 2018-03-13 | ||
| 2017-09-30 | $63.05M 10-K · filed 2018-03-13 | $125.32M derived: sum of 2 quarters · filed 2018-08-06 | $190.82M 10-Q · filed 2017-11-13 | $243.23M derived: sum of 4 quarters · filed 2018-08-06 | ||
| 2017-06-30 | $62.26M 10-Q · filed 2018-08-06 | $66.09M 10-Q · filed 2017-08-07 | $119.69M 10-Q · filed 2018-08-06 | $127.77M 10-Q · filed 2017-08-07 | $180.18M derived: sum of 3 quarters · filed 2018-08-06 | $240.94M derived: sum of 4 quarters · filed 2018-08-06 |
| 2017-03-31 | $57.43M 10-Q · filed 2018-05-08 | $61.68M 10-Q · filed 2017-05-09 | $117.92M derived: sum of 2 quarters · filed 2018-05-08 | $178.68M derived: sum of 3 quarters · filed 2018-05-08 | $241.81M derived: sum of 4 quarters · filed 2018-05-08 | |
| 2016-12-31 | $60.49M 10-K · filed 2018-03-13 | $121.25M derived: sum of 2 quarters · filed 2018-03-13 | $184.38M derived: sum of 3 quarters · filed 2018-03-13 | $244.08M 10-K · filed 2018-03-13 | ||
| 2016-09-30 | $60.76M 10-K · filed 2018-03-13 | $123.89M derived: sum of 2 quarters · filed 2018-03-13 | $183.59M 10-Q · filed 2017-11-13 | $210.87M derived: sum of 4 quarters · filed 2018-03-13 | ||
| 2016-06-30 | $63.13M 10-K · filed 2018-03-13 | $122.83M 10-Q · filed 2017-08-07 | $150.11M derived: sum of 3 quarters · filed 2018-03-13 | $175.24M derived: sum of 4 quarters · filed 2018-03-13 | ||
| 2016-03-31 | $59.70M 10-K · filed 2018-03-13 | $86.98M derived: sum of 2 quarters · filed 2018-03-13 | $112.11M derived: sum of 3 quarters · filed 2018-03-13 | $136.48M derived: sum of 4 quarters · filed 2018-03-13 | ||
| 2015-12-31 | $27.28M 10-K · filed 2017-03-14 | $52.41M derived: sum of 2 quarters · filed 2017-03-14 | $76.78M derived: sum of 3 quarters · filed 2017-03-14 | $99.80M 10-K · filed 2018-03-13 | ||
| 2015-09-30 | $25.13M 10-K · filed 2017-03-14 | $49.50M derived: sum of 2 quarters · filed 2017-03-14 | $72.52M 10-Q · filed 2016-11-07 | $97.52M derived: sum of 4 quarters · filed 2017-03-14 | ||
| 2015-06-30 | $24.37M 10-K · filed 2017-03-14 | $47.40M 10-Q · filed 2016-08-05 | $72.40M derived: sum of 3 quarters · filed 2017-03-14 | $95.61M derived: sum of 4 quarters · filed 2017-03-14 | ||
| 2015-03-31 | $23.03M 10-K · filed 2017-03-14 | $48.03M derived: sum of 2 quarters · filed 2017-03-14 | $71.24M derived: sum of 3 quarters · filed 2017-03-14 | $91.91M derived: sum of 4 quarters · filed 2017-03-14 | ||
| 2014-12-31 | $25.00M 10-K · filed 2016-04-18 | $48.22M derived: sum of 2 quarters · filed 2016-04-18 | $68.89M derived: sum of 3 quarters · filed 2016-04-18 | $87.07M 10-K · filed 2017-03-14 | ||
| 2014-09-30 | $23.22M 10-K · filed 2016-04-18 | $43.89M derived: sum of 2 quarters · filed 2016-04-18 | $62.07M 10-Q · filed 2015-11-06 | $80.39M derived: sum of 4 quarters · filed 2016-04-18 | ||
| 2014-06-30 | $20.67M 10-K · filed 2016-04-18 | $38.85M 10-Q · filed 2015-07-31 | $57.17M derived: sum of 3 quarters · filed 2016-04-18 | $74.06M derived: sum of 4 quarters · filed 2016-04-18 | ||
| 2014-03-31 | $18.18M 10-K · filed 2016-04-18 | $36.51M derived: sum of 2 quarters · filed 2016-04-18 | $53.39M derived: sum of 3 quarters · filed 2016-04-18 | $68.99M derived: sum of 4 quarters · filed 2016-04-18 | ||
| 2013-12-31 | $18.32M 10-K · filed 2014-02-24 | $35.21M derived: sum of 2 quarters · filed 2014-11-04 | $50.81M derived: sum of 3 quarters · filed 2014-11-04 | $66.47M 10-K · filed 2016-04-18 | ||
| 2013-09-30 | $16.88M 10-Q · filed 2014-11-04 | $32.49M derived: sum of 2 quarters · filed 2014-11-04 | $48.14M 10-Q · filed 2014-11-04 | $63.04M derived: sum of 4 quarters · filed 2014-11-04 | ||
| 2013-06-30 | $15.60M 10-Q · filed 2014-07-29 | $31.26M 10-Q · filed 2014-07-29 | $46.15M derived: sum of 3 quarters · filed 2014-07-29 | $60.36M derived: sum of 4 quarters · filed 2014-07-29 | ||
| 2013-03-31 | $15.66M 10-Q · filed 2014-05-12 | $30.55M derived: sum of 2 quarters · filed 2014-05-12 | $44.75M derived: sum of 3 quarters · filed 2014-05-12 | $60.36M derived: sum of 4 quarters · filed 2014-05-12 | ||
| 2012-12-31 | $14.89M 10-K · filed 2014-02-24 | $29.10M derived: sum of 2 quarters · filed 2014-02-24 | $44.71M derived: sum of 3 quarters · filed 2014-02-24 | $59.87M 10-K · filed 2015-03-03 | ||
| 2012-09-30 | $14.20M 10-K · filed 2014-02-24 | $29.81M derived: sum of 2 quarters · filed 2014-02-24 | $44.97M 10-Q · filed 2013-10-30 | $57.87M derived: sum of 4 quarters · filed 2014-02-24 | ||
| 2012-06-30 | $15.61M 10-K · filed 2014-02-24 | $30.77M 10-Q · filed 2013-08-02 | $43.66M derived: sum of 3 quarters · filed 2014-02-24 | $54.98M derived: sum of 4 quarters · filed 2014-02-24 | ||
| 2012-03-31 | $15.16M 10-K · filed 2014-02-24 | $28.05M derived: sum of 2 quarters · filed 2014-02-24 | $39.37M derived: sum of 3 quarters · filed 2014-02-24 | $49.84M derived: sum of 4 quarters · filed 2014-02-24 | ||
| 2011-12-31 | $12.89M 10-K · filed 2014-02-24 | $24.21M derived: sum of 2 quarters · filed 2014-02-24 | $34.68M derived: sum of 3 quarters · filed 2014-02-24 | $43.48M 10-K · filed 2014-02-24 | ||
| 2011-09-30 | $11.32M 10-K · filed 2014-02-24 | $21.79M derived: sum of 2 quarters · filed 2014-02-24 | $30.59M 10-Q · filed 2012-11-05 | $39.35M derived: sum of 4 quarters · filed 2014-02-24 | ||
| 2011-06-30 | $10.47M 10-K · filed 2014-02-24 | $19.27M 10-Q/A · filed 2012-08-15 | $28.03M derived: sum of 3 quarters · filed 2014-02-24 | $36.73M derived: sum of 4 quarters · filed 2014-02-24 | ||
| 2011-03-31 | $8.80M 10-K · filed 2014-02-24 | $17.56M derived: sum of 2 quarters · filed 2014-02-24 | $26.27M derived: sum of 3 quarters · filed 2014-02-24 | $34.76M derived: sum of 4 quarters · filed 2014-02-24 | ||
| 2010-12-31 | $8.76M derived: 10-K 12 month − 10-Q 9 month · filed 2012-03-12 | $17.46M derived: sum of 2 quarters · filed 2012-03-12 | $25.95M derived: sum of 3 quarters · filed 2012-03-12 | $34.37M 10-K · filed 2012-03-12 | ||
| 2010-09-30 | $8.71M 10-Q · filed 2011-10-25 | $17.20M derived: sum of 2 quarters · filed 2011-10-25 | $25.62M 10-Q · filed 2011-10-25 | |||
| 2010-06-30 | $8.49M 10-Q/A · filed 2011-08-01 | $16.91M 10-Q/A · filed 2011-08-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| 20/20 Biolabs, Inc. (AIDX) | United States | $0.005B |